Table III Enrichment results from a pan-cancer survival analysis
Cancer typeNumber of enriched pathways, upregulatedNumber of enriched pathways after set cover, upregulatedNumber of enriched pathways, downregulatedNumber of enriched pathways after set cover, downregulated
Bladder454377
Breast001616
Colorectal002220
Kidney15141111
Leukemia292400
Lung393411
Endometrial1155